The therapeutic effects of PJ34. [N-(6-Oxo-5,6-dihydrophenanthridin-2-yl)- N,N-dimethylacetamide, HCl], a selective inhibitor of poly(ADP-ribose) polymerase, in experimental allergic encephalomyelitis are associated with immunomodulation
Gwen S. Scott
, Rhonda B. Kean
, Tatiana Mikheeva
, Marzena J. Fabis
, Jon G. Mabley
, Csaba Szabó
, D. Craig Hooper
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'The therapeutic effects of PJ34. [N-(6-Oxo-5,6-dihydrophenanthridin-2-yl)- N,N-dimethylacetamide, HCl], a selective inhibitor of poly(ADP-ribose) polymerase, in experimental allergic encephalomyelitis are associated with immunomodulation'. Together they form a unique fingerprint.
Keyphrases
Pharmacology, Toxicology and Pharmaceutical Science